Apheresis for idiopathic sudden hearing loss: Reviewing the evidence

Journal of Clinical Apheresis

Volumn 21, Issue 4, 2006, Pages 241-245

  Finger, Robert P ^a,b   Gostian, Antoniu O ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b CURTIN UNIVERSITY   (Australia)

^c Neuss City Hospital   (Germany)

Author keywords

Plasma proteins; Plasmapheresis; Sensorineural hearing loss; Viscosity

Indexed keywords

ALPHA 2 MACROGLOBULIN; FIBRINOGEN; FIBRONECTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMA PROTEIN; VON WILLEBRAND FACTOR;

AGE; APHERESIS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE KINETICS; HUMAN; HYPERVISCOSITY SYNDROME; IDIOPATHIC DISEASE; INCIDENCE; MICROANGIOPATHY; PLASMAPHERESIS; QUALITY OF LIFE; SAFETY; SHORT SURVEY; SOCIAL INTERACTION; SUDDEN DEAFNESS; TREATMENT OUTCOME;

BLOOD COMPONENT REMOVAL; BLOOD VISCOSITY; COCHLEA; FIBRINOGEN; HEARING LOSS, SUDDEN; HUMANS; IMMUNOSORBENT TECHNIQUES; MICROCIRCULATION; RISK FACTORS; TREATMENT OUTCOME;

EID: 33845962615     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20081     Document Type: Short Survey

References (30)

1. Koc A, Sanisoglu O. Sudden sensorineural hearing loss: Literature review on recent studies. J Otolaryngol 2003;32:308-313.
2. Nakashima T, Itoh A, Misawa H, Ohno Y. Clinicoepidemiologic features of sudden deafness diagnosed and treated at university hospitals in Japan. Otolaryngol Head Neck Surg 2000;123:593-597.
3. Klemm E, Schaarschmidt W. Epidemiological survey on sudden deafness, vestibular dysfunctions and Meniere's Disease [in German]. HNO-Praxis 1989;14:295-299.
4. Heiden C, Porzsolt F, Biesinger E, Hoing R. Spontaneous remission of sudden deafness. Hno 2000;48:621-623.
5. Fuse T, Aoyagi M, Funakubo T, Sakukibara A, Yoshida S. Short-term outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid. ORL J Otorhinolaryngol Relat Spec 2002;64:6-10.
6. Tamhankar M, Solomon D. Acute Hearing Loss. Curr Treat Options Neurol 2004;6:55-65.
7. Selmani Z, Pyykko I, Ishizaki H, Marttila TI. Cochlear blood How measurement in patients with Meniere's disease and other inner ear disorders. Acta Otolaryngol Suppl 2001;545:10-13.
8. Hirano K, Ikeda K, Kawase T, Oshima T, Kekchata S, Takahashi S, Sato T, Kobayashi T, Takasaka T. Prognosis of sudden deafness with special reference to risk factors of microvascular pathology. Auris Nasus Larynx 1999;26:111-115.
9. Valbonesi M, Mora F, Mora R, Carlier P. Rheopheresis for sudden hearing loss (SHL). Int J Artif Organs 2004;27:806-809.
10. Fowler EP, Jr. Intra-venule phenomena. Acta Otolaryngol 1961;53:107-115.
11. Maass B. Blood supply of the internal car. Anatomico-functional considerations. Hno 1982;30:355-364.
12. Ohinata Y, Makimoto K, Kawakami M, Haginomori S, Araki M, Takahashi H. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol 1994;114:601-607.
13. Suckfüll M, Thiery J, Wimmer C, Mees K, Schorn K. Hypercholesteremia and hyperfibrinogenemia in sudden deafness. Laryngorhinootologie 1997;76:453-457.
14. Shiraishi T, Kubo T, Matsunaga T. Chronological study of recovery of sudden deafness treated with defibrinogenation and steroid therapies. Acta Otolaryngol 1991;111:867-871.
15. Asakura M, Kato I, Takahashi K, Okada T, Minami S, Takeyama I, Ohnuki T. Increased platelet aggregability in patients with vertigo, sudden deafness and facial palsy. Acta Otolaryngol Suppl 1995;520:399-400.
16. Klemm E, Altmann E, Lange O. Rheologic problems of microcirculation and consequences of drug therapy for sudden deafness. Laryngol Rhinol Otol (Stuttgart) 1983;62:62-64.
17. Wilke H, Grossgerge H, Haubold E, Kahlke W, Frahm H, Regler B. Frequency and distribution of risk factors in hearing loss. Fortschr Med 1977;95:1757-1764.
18. Schmolke B, Hermann K. Vascular risk factors of sudden deafness and its incidence in the normal population. A retrospective study. Hno 1990;38:440-445.
19. Ziegler EA, Hohlweg-Majert B, Maurer J, Mann WJ. Epidemiological data of patients with sudden hearing loss: a retrospective study over a period of three years. Laryngorhinootologie 2003;82:4-8.
20. Suckfüll M. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002;360:1811-1817.
21. Ullrich H, Klcinjung T, Steffens T, Jacob P, Schmitz G, Strutz J. Improved treatment of sudden hearing loss by specific fibrinogen aphaeresis. J Clin Apheresis 2004;19:71-78.
22. Tietz NW. Textbook of clinical chemistry. Philadelphia: W.B. Saunders Company: 1986. p 1835.
23. National Center for Health Statistics. Health. United States, 2004. With Chartbook on Trends in the Health of Americans. Hyattsville, MD: U.S. Government Printing Office; 2004.
24. Onat A. Lipids, lipoproteins and apolipoproteins among Turks, and impact on coronary heart disease. Anadolu Kardiyol Derg 2004;4:236-245.
25. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Jama 1998;279:1477-1482.
26. Imperatore G, Riccardi G, Iovine C, Rivellese AA, Vaccaro O. Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care 1998;21:649-654.
27. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 2004;18:139-147.
28. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O. Reference distributions for alpha2-macroglobulin: a comparison of a large cohort to the world's literature. J Clin Lab Anal 2004;18:148-152.
29. Seligman BG, Biolo A, Polanczyk CA, Gross JL, Clausell N. Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia. Diabetes Care 2000;23:1395-1400.
30. Cucuianu M, Bodizs G, Duncea I, Colhon D. Plasma fibronectin in overweight men and women: correlation with serum triglyceride levels and serum cholinesterase activity. Blood Coagul Fibrinolysis 1996;7:779-785.